Global Orally Disintegrating Tablet Excipient Competitive Landscape Professional Research Report 2025
Description
Global Orally Disintegrating Tablet Excipient Competitive Landscape Professional Research Report 2025
Research Summary
Orally disintegrating tablet (ODT) excipients are an essential component of ODT formulations. They are non-active ingredients added to ODTs to provide various functions, such as improving the tablet＇s taste, enhancing its disintegration properties, ensuring stability, and facilitating manufacturing processes. Common ODT excipients include superdisintegrants like crospovidone or croscarmellose sodium, which aid in the tablet＇s rapid dissolution in saliva, as well as sweeteners, flavors, and colorants to make the tablet more palatable. In addition, binding agents, fillers, and lubricants are used to ensure tablet integrity and assist in the manufacturing process. ODT excipients are carefully selected to achieve the desired balance of taste, texture, and performance, allowing for a convenient and effective delivery of medications that dissolve quickly in the mouth without the need for water.
According to DIResearch's in-depth investigation and research, the global Orally Disintegrating Tablet Excipient market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Orally Disintegrating Tablet Excipient include BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Merck, Ashland, Meggle Pharma, Evonik, Shin-Etsu, Fuji Chemical Industries, McePharma, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Orally Disintegrating Tablet Excipient. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Orally Disintegrating Tablet Excipient market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Orally Disintegrating Tablet Excipient market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Orally Disintegrating Tablet Excipient industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Orally Disintegrating Tablet Excipient Include:
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Merck
Ashland
Meggle Pharma
Evonik
Shin-Etsu
Fuji Chemical Industries
McePharma
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
Orally Disintegrating Tablet Excipient Product Segment Include:
Binders
Glidents
Diluents
Disintegrants
Others
Orally Disintegrating Tablet Excipient Product Application Include:
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Orally Disintegrating Tablet Excipient Industry PESTEL Analysis
Chapter 3: Global Orally Disintegrating Tablet Excipient Industry Porter’s Five Forces Analysis
Chapter 4: Global Orally Disintegrating Tablet Excipient Major Regional Market Size and Forecast Analysis
Chapter 5: Global Orally Disintegrating Tablet Excipient Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Orally Disintegrating Tablet Excipient Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Orally Disintegrating Tablet Excipient Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Orally Disintegrating Tablet Excipient Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Orally Disintegrating Tablet Excipient Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Orally Disintegrating Tablet Excipient Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Orally Disintegrating Tablet Excipient Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Orally Disintegrating Tablet Excipient Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Orally Disintegrating Tablet Excipient Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Orally Disintegrating Tablet Excipient Product by Type
- 1.2.1 Binders
- 1.2.2 Glidents
- 1.2.3 Diluents
- 1.2.4 Disintegrants
- 1.2.5 Others
- 1.3 Orally Disintegrating Tablet Excipient Product by Application
- 1.3.1 Anti-Psychotics Drug
- 1.3.2 Anti-Epileptics Drug
- 1.3.3 Others
- 1.4 Global Orally Disintegrating Tablet Excipient Market Size Analysis (2020-2032)
- 1.5 Orally Disintegrating Tablet Excipient Market Development Status and Trends
- 1.5.1 Orally Disintegrating Tablet Excipient Industry Development Status Analysis
- 1.5.2 Orally Disintegrating Tablet Excipient Industry Development Trends Analysis
- 2 Orally Disintegrating Tablet Excipient Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Orally Disintegrating Tablet Excipient Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Orally Disintegrating Tablet Excipient Market Analysis by Regions
- 4.1 Orally Disintegrating Tablet Excipient Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Orally Disintegrating Tablet Excipient Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Region (2026-2032)
- 5 Global Orally Disintegrating Tablet Excipient Market Size by Type and Application
- 5.1 Global Orally Disintegrating Tablet Excipient Market Size by Type (2020-2032)
- 5.2 Global Orally Disintegrating Tablet Excipient Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Orally Disintegrating Tablet Excipient Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Orally Disintegrating Tablet Excipient Market Size by Type
- 6.4 North America Orally Disintegrating Tablet Excipient Market Size by Application
- 6.5 North America Orally Disintegrating Tablet Excipient Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Orally Disintegrating Tablet Excipient Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Orally Disintegrating Tablet Excipient Market Size by Type
- 7.4 Europe Orally Disintegrating Tablet Excipient Market Size by Application
- 7.5 Europe Orally Disintegrating Tablet Excipient Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Orally Disintegrating Tablet Excipient Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Orally Disintegrating Tablet Excipient Market Size by Type
- 8.4 China Orally Disintegrating Tablet Excipient Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Orally Disintegrating Tablet Excipient Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Orally Disintegrating Tablet Excipient Market Size by Type
- 9.4 APAC (excl. China) Orally Disintegrating Tablet Excipient Market Size by Application
- 9.5 APAC (excl. China) Orally Disintegrating Tablet Excipient Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Orally Disintegrating Tablet Excipient Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Orally Disintegrating Tablet Excipient Market Size by Type
- 10.4 Latin America Orally Disintegrating Tablet Excipient Market Size by Application
- 10.5 Latin America Orally Disintegrating Tablet Excipient Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Orally Disintegrating Tablet Excipient Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Orally Disintegrating Tablet Excipient Market Size by Type
- 11.4 Middle East & Africa Orally Disintegrating Tablet Excipient Market Size by Application
- 11.5 Middle East & Africa Orally Disintegrating Tablet Excipient Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Orally Disintegrating Tablet Excipient Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Orally Disintegrating Tablet Excipient Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Orally Disintegrating Tablet Excipient Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 BASF
- 13.1.1 BASF Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 BASF Orally Disintegrating Tablet Excipient Product Portfolio
- 13.1.3 BASF Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 JRS Pharma
- 13.2.1 JRS Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolio
- 13.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Roquette
- 13.3.1 Roquette Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Roquette Orally Disintegrating Tablet Excipient Product Portfolio
- 13.3.3 Roquette Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 ABF Ingredients
- 13.4.1 ABF Ingredients Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolio
- 13.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 DFE Pharma
- 13.5.1 DFE Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolio
- 13.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Merck
- 13.6.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Merck Orally Disintegrating Tablet Excipient Product Portfolio
- 13.6.3 Merck Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Ashland
- 13.7.1 Ashland Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Ashland Orally Disintegrating Tablet Excipient Product Portfolio
- 13.7.3 Ashland Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Meggle Pharma
- 13.8.1 Meggle Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolio
- 13.8.3 Meggle Pharma Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Evonik
- 13.9.1 Evonik Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Evonik Orally Disintegrating Tablet Excipient Product Portfolio
- 13.9.3 Evonik Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Shin-Etsu
- 13.10.1 Shin-Etsu Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolio
- 13.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Fuji Chemical Industries
- 13.11.1 Fuji Chemical Industries Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolio
- 13.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 McePharma
- 13.12.1 McePharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 McePharma Orally Disintegrating Tablet Excipient Product Portfolio
- 13.12.3 McePharma Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Cargill Incorporated
- 13.13.1 Cargill Incorporated Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolio
- 13.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Daicel Corporation
- 13.14.1 Daicel Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolio
- 13.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Anhui Sunhere Pharmaceutical
- 13.15.1 Anhui Sunhere Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolio
- 13.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Orally Disintegrating Tablet Excipient Industry Chain Analysis
- 14.2 Orally Disintegrating Tablet Excipient Industry Raw Material and Suppliers Analysis
- 14.2.1 Orally Disintegrating Tablet Excipient Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Orally Disintegrating Tablet Excipient Typical Downstream Customers
- 14.4 Orally Disintegrating Tablet Excipient Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
